Host-derived Langerhans cells persist after MHC-matched allografting independent of donor T cells and critically influence the alloresponses mediated by donor lymphocyte infusions

Journal of Immunology

Volumn 177, Issue 7, 2006, Pages 4414-4425

  Durakovic, Nadira ^a   Bezak, Karl B ^a   Skarica, Mario ^a   Radojcic, Vedran ^a   Fuchs, Ephraim J ^a   Murphy, George F ^b   Luznik, Leo ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD;

ADOPTIVE TRANSFER; ALLOGRAFT; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CHIMERA; CONTROLLED STUDY; DENDRITIC CELL; DONOR; GRAFT VERSUS HOST REACTION; HISTOCOMPATIBILITY; HISTOPATHOLOGY; LANGERHANS CELL; LYMPHOCYTE TRANSFER; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN; T LYMPHOCYTE;

EID: 33749129345     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.7.4414     Document Type: Article

References (62)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
2. Lanzavecchia, A., and F. Sallusto. 2001. The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr. Opin. Immunol. 13: 291-298.
3. Korngold, R., and J. Sprent. 1982. Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers. J. Exp. Med. 155: 872-883.
4. + T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J. Exp. Med. 165: 1552-1564.
5. Korngold, R., and J. Sprent. 1991. Graft-versus-host disease in experimental allogeneic bone marrow transplantation. Proc. Soc. Exp. Biol. Med. 197: 12-18.
6. + T cells each can utilize a perforin-dependent pathway to mediate lethal graft-versus-host disease in major histocompatibility complex-disparate recipients. Transplantation 64: 571-576.
7. Brochu, S., B. Rioux-Masse, J. Roy, D. C. Roy, and C. Perreault. 1999. Massive activation-induced cell death of alloreactive T cells with apoptosis of bystander postthymic T cells prevents immune reconstitution in mice with graft-versus-host disease. Blood 94: 390-400.
8. Graubert, T. A., J. F. DiPersio, J. H. Russell, and T. J. Ley. 1997. Perforin/granzyme-dependent and independent mechanisms are both important for the development of graft-versus-host disease after murine bone marrow transplantation. J. Clin. Invest. 100: 904-911.
9. Schmaltz, C., O. Alpdogan, K. J. Horndasch, S. J. Muriglan, B. J. Kappel, T. Teshima, J. L. Ferrara, S. J. Burakoff, and M. R. van den Brink. 2001. Differential use of Fas ligand and perform cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 97: 2886-2895.
10. Reddy, P., Y. Maeda, C. Liu, O. I. Krijanovski, R. Korngold, and J. L. Ferrara. 2005. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat. Med. 11: 1244-1249.
11. Matte, C. C., J. Liu, J. Cormier, B. E. Anderson, I. Athanasiadis, D. Jain, J. McNiff, and W. D. Shlomchik. 2004. Donor APCs are required for maximal GVHD but not for GVL. Nat. Med. 10: 987-992.
12. Merad, M., P. Hoffmann, E. Ranheim, S. Slaymaker, M. G. Manz, S. A. Lira, I. Charo, D. N. Cook, I. L. Weissman, S. Strober, and E. G. Engleman. 2004. Depletion of host Langerhans cells before transplantation of donor alloreactive T cells prevents skin graft-versus-host disease. Nat. Med. 10: 510-517.
13. Mapara, M. Y., Y. M. Kim, S. P. Wang, R. Bronson, D. H. Sachs, and M. Sykes. 2002. Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells. Blood 100: 1903-1909.
14. Teshima, T., R. Ordemann, P. Reddy, S. Gagin, C. Liu, K. R. Cooke, and J. L. Ferrara. 2002. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat. Med. 8: 575-581.
15. Shlomchik, W. D., M. S. Couzens, C. B. Tang, J. McNiff, M. E. Robert, J. Liu, M. J. Shlomchik, and S. G. Emerson. 1999. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285: 412-415.
16. + T cell-mediated graft-versus-host disease model. J. Clin. Invest. 112: 1880-1886.
17. Shlomchik, W. D. 2003. Antigen presentation in graft-vs-host disease. Exp. Hematol. 31: 1187-1197.
18. Song, H. K., H. Noorchashm, Y. K. Lieu, S. Rostami, S. A. Greeley, C. F. Barker, and A. Naji. 1999. Cutting edge: alloimmune responses against major and minor histocompatibility antigens: distinct division kinetics and requirement for CD28 costimulation. J. Immunol. 162: 2467-2471.
19. Luznik, L., S. Jalla, L. W. Engstrom, R. Iannone, and E. J. Fuchs. 2001. Durable engraftment of major histocompatibility complex-incompatible cells after non-myeloablative conditioning with fludarabine, low-dose total body irradiation, and posttransplantation cyclophosphamide. Blood 98: 3456-3464.
20. Henri, S., D. Vremec, A. Kamath, J. Waithman, S. Williams, C. Benoist, K. Burnham, S. Saeland, E. Handman, and K. Shortman. 2001. The dendritic cell populations of mouse lymph nodes. J. Immunol. 167: 741-748.
21. Kamath, A. T., J. Pooley, M. A. O'Keeffe, D. Vremec, Y. Zhan, A. M. Lew, A. D'Amico, L. Wu, D. F. Tough, and K. Shortman. 2000. The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J. Immunol. 165: 6762-6770.
22. + T cell-mediated acute graft-versus-host disease. J. Clin. Invest. 109: 1335-1344.
23. Merad, M., M. G. Manz, H. Karsunky, A. Wagers, W. Peters, I. Charo, I. L. Weissman, J. G. Cyster, and E. G. Engleman. 2002. Langerhans cells renew in the skin throughout life under steady-state conditions. Nat. Immunol. 3: 1135-1141.
24. Schuler, G., and R. M. Steinman. 1985. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J. Exp. Med. 161: 526-546.
25. + dendritic cells but not by Langerhans cells. Science 301: 1925-1928.
26. Inaba, K., M. Pack, M. Inaba, H. Sakuta, F. Isdell, and R. M. Steinman. 1997. High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J. Exp. Med. 186: 665-672.
27. Cooke, K. R., L. Kobzik, T. R. Martin, J. Brewer, J. Delmonte, Jr., J. M. Crawford, and J. L. Ferrara. 1996. An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin. Blood 88: 3230-3239.
28. Hill, G. R., K. R. Cooke, T. Teshima, J. M. Crawford, J. C. Keith, Jr., Y. S. Brinson, D. Bungard, and J. L. Ferrara. 1998. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. J. Clin. Invest. 102: 115-123.
29. + effector cells. Am. J. Pathol. 138: 983-990.
30. Ferrara, J., F. J. Guillen, B. Sleckman, S. J. Burakoff, and G. F. Murphy. 1986. Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease. J. Invest. Dermatol. 86: 371-375.
31. Hill, G. R., J. M. Crawford, K. R. Cooke, Y. S. Brinson, L. Pan, and J. L. Ferrara. 1997. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 90: 3204-3213.
32. Kolb, H., G. E. Sale, K. G. Lerner, R. Storb, and E. D. Thomas. 1979. Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs. Am. J. Pathol. 96: 581-594.
33. Zhang, Y., G. Joe, E. Hexner, J. Zhu, and S. G. Emerson. 2005. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease. J. Immunol. 174: 3051-3058.
34. Shortman, K., and Y. J. Liu. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2: 151-161.
35. high dendritic cell subsets as revealed by baseline gene expression patterns. J. Immunol. 171: 47-60.
36. Vremec, D., J. Pooley, H. Hochrein, L. Wu, and K. Shortman. 2000. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen. J. Immunol. 164: 2978-2986.
37. Luznik, L., L. W. Engstrom, R. Iannone, and E. J. Fuchs. 2002. Posttransplantation cyclophosphamide facilitates engraftment of major histocompatibility complex-identical allogeneic marrow in mice conditioned with low-dose total body irradiation. Biol. Blood Marrow Transplant. 8: 131-138.
38. Wilson, N. S., D. El-Sukkari, G. T. Belz, C. M. Smith, R. J. Steptoe, W. R. Heath, K. Shortman, and J. A. Villadangos. 2003. Most lymphoid organ dendritic cell types are phenotypically and functionally immature. Blood 102: 2187-2194.
39. Stoitzner, P., S. Holzmann, A. D. McLellan, L. Ivarsson, H. Stossel, M. Kapp, U. Kammerer, P. Douillard, E. Kampgen, F. Koch, et al. 2003. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J. Invest. Dermatol. 120: 266-274.
40. Borkowski, T. A., A. J. Nelson, A. G. Farr, and M. C. Udey. 1996. Expression of gp40, the murine homologue of human epithelial cell adhesion molecule (Ep-CAM), by murine dendritic cells. Eur. J. Immunol. 26: 110-114.
41. Ruedl, C., P. Koebel, M. Bachmann, M. Hess, and K. Karjalainen. 2000. Anatomical origin of dendritic cells determines their life span in peripheral lymph nodes. J. Immunol. 165: 4910-4916.
42. Zhao, X., E. Deak, K. Soderberg, M. Linehan, D. Spezzano, J. Zhu, D. M. Knipe, and A. Iwasaki. 2003. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197: 153-162.
43. Katz, S. I., K. Tamaki, and D. H. Sachs. 1979. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282: 324-326.
44. Ohl, L., M. Mohaupt, N. Czeloth, G. Hintzen, Z. Kiafard, J. Zwimer, T. Blankenstein, G. Henning, and R. Forster. 2004. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 21: 279-288.
45. Randolph, G. J. 2002. Is maturation required for Langerhans cell migration? J. Exp. Med. 196: 413-416.
46. Yoshino, M., H. Yamazaki, H. Nakano, T. Kakiuchi, K. Ryoke, T. Kunisada, and S. Hayashi. 2003. Distinct antigen trafficking from skin in the steady and active states. Int. Immunol. 15: 773-779.
47. Mayerova, D., E. A. Parke, L. S. Bursch, O. A. Odumade, and K. A. Hogquist. 2004. Langerhans cells activate naive self-antigen-specific CD8 T cells in the steady state. Immunity 21: 391-400.
48. Kamath, A. T., S. Henri, F. Battye, D. F. Tough, and K. Shortman. 2002. Developmental kinetics and lifespan of dendritic ceils in mouse lymphoid organs. Blood 100: 1734-1741.
49. Garg, S., A. Oran, J. Wajchman, S. Sasaki, C. H. Maris, J. A. Kapp, and J. Jacob. 2003. Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat. Immunol. 4: 907-912.
50. Lapp, W. S., T. Ghayur, M. Mendes, M. Seddik, and T. A. Seemayer. 1985. The functional and histological basis for graft-versus-host-induced immunosuppression. Immunol. Rev. 88: 107-133.
51. Hemmi, H., T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda, and S. Akira. 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3: 196-200.
52. Nair, S., C. McLaughlin, A. Weizer, Z. Su, D. Boczkowski, J. Dannull, J. Vieweg, and E. Gilboa. 2003. Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturation. J. Immunol. 171: 6275-6282.
53. Palamara, F., S. Meindl, M. Holcmann, P. Luhrs, G. Stingl, and M. Sibilia. 2004. Identification and characterization of pDC-like cells in normal mouse skin and melanomas treated with imiquimod. J. Immunol. 173: 3051-3061.
54. Suzuki, H., B. Wang, G. M. Shivji, P. Toto, P. Amerio, M. A. Tomai, R. L. Miller, and D. N. Sauder. 2000. Imiquimod, a topical immune response modifier, induces migration of Langerhans cells. J. Invest. Dermatol. 114: 135-141.
55. + T cells to elicit hepatic graft-versus-host disease. J. Immunol. 169: 7111-7118.
56. Heidt, P. J., and J. M. Vossen. 1992. Experimental and clinical gnotobiotics: influence of the microflora on graft-versus-host disease after allogeneic bone marrow transplantation. J. Med. 23: 161-173.
57. Sherman, L. A., and S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11: 385-402.
58. Burakoff, S. J., R. Finberg, L. Glimcher, F. Lemonnier, B. Benacerraf, and H. Cantor. 1978. The biologic significance of alloreactivity: the ontogeny of T-cell sets specific for alloantigens or modified self antigens. J. Exp. Med. 148: 1414-1422.
59. Collin, M. P., D. N. Hart, G. H. Jackson, G. Cook, J. Cavet, S. Mackinnon, P. G. Middleton, and A. M. Dickinson. 2006. The fate of human Langerhans cells in hematopoietic stem cell transplantation. J. Exp. Med. 203: 27-33.
60. Hemmi, H., M. Yoshino, H. Yamazaki, M. Naito, T. Iyoda, Y. Omatsu, S. Shimoyama, J. J. Letterio, T. Nakabayashi, H. Tagaya, et al. 2001. Skin antigens in the steady state are trafficked to regional lymph nodes by transforming growth factor-β1-dependent cells. Int. Immunol. 13: 695-704.
61. Hessel, H., J. Mittermuller, H. Zitzelsberger, H. U. Weier, and M. Bauchinger. 1996. Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation. Histochem. Cell. Biol. 106: 481-485.
62. Perreault, C., M. Pelletier, R. Belanger, J. Boileau, Y. Bonny, M. David, M. Gyger, D. Landry, and S. Montplaisir. 1985. Persistence of host Langerhans cells following allogeneic bone marrow transplantation: possible relationship with acute graft-versus-host disease. Br. J. Haematol. 60: 253-260.